Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Marian D. Witvliet"'
Autor:
Karlijn A M I van der Pant, Henny G. Otten, Sebastiaan Heidt, Ineke J. M. ten Berge, Bram W. Wisse, Mariëlle A C J Gelens, Michiel L. Bots, Paul J M van der Boog, Marissa J. H. van der Linden-van Oevelen, Annechien J. A. Lambeck, Wendy Swelsen, N M Lardy, Frans J. van Ittersum, Dave L. Roelen, Andries J. Hoitsma, Franka E. van Reekum, Arnold van der Meer, Johan W. de Fijter, Jan-Stephan F. Sanders, Adriaan C.A.D. Drop, Shaikh A. Nurmohamed, Elena G. Kamburova, Bouke G. Hepkema, Cornelis E. Hack, Marije C. Baas, Geert W. Haasnoot, Marian D. Witvliet, Luuk B. Hilbrands, Caroline Roozendaal, Arjan D. van Zuilen, Wil A. Allebes, Michiel G. H. Betjes, Marcel G.J. Tilanus, Loes Plaisier, Elly M. van Duijnhoven, Lotte Wieten, Frans H.J. Claas, Maarten H. L. Christiaans, Neelke C. van der Weerd, Marc A. Seelen, Frederike J. Bemelman, Christina E.M. Voorter, Eric Spierings, Laura Bungener, Irma Joosten, Marianne C. Verhaar
Publikováno v:
Heidt, S, Haasnoot, G W, Witvliet, M D, van der Linden-van Oevelen, M J H, Kamburova, E G, Wisse, B W, Joosten, I, Allebes, W A, van der Meer, A, Hilbrands, L B, Baas, M C, Spierings, E, Hack, C E, van Reekum, F E, van Zuilen, A D, Verhaar, M C, Bots, M L, Drop, A C A D, Plaisier, L, Seelen, M A J, Sanders, J-S, Hepkema, B G, Lambeck, A J A, Bungener, L B, Roozendaal, C, Tilanus, M G J, Voorter, C E, Wieten, L, van Duijnhoven, E M, Gelens, M A C J, Christiaans, M H L, van Ittersum, F J, Nurmohamed, S A, Lardy, N M, Swelsen, W, van der Pant, K A M I, van der Weerd, N C, ten Berge, I J M, Bemelman, F J, Hoitsma, A, van der Boog, P J M, de Fijter, J W, Betjes, M G H, Otten, H G, Roelen, D L & Claas, F H J 2019, ' Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients ', American Journal of Transplantation, vol. 19, no. 10, pp. 2926-2933 . https://doi.org/10.1111/ajt.15486
American Journal of Transplantation, 19(10), 2926-2933. Wiley-Blackwell
American journal of transplantation, 19(10), 2926-2933. Wiley-Blackwell
American Journal of Transplantation, 19, 10, pp. 2926-2933
American Journal of Transplantation
American Journal of Transplantation, 19(10), 2926-2933
American Journal of Transplantation, 19(10), 2926-2933. Wiley-Blackwell Publishing Ltd
American Journal of Transplantation, 19(10), 2926. Blackwell Publishing Asia Pty Ltd
American Journal of Transplantation, 19(10), 2926-2933. Wiley
American Journal of Transplantation, 19, 2926-2933
American Journal of Transplantation, 19(10), 2926-2933. Wiley-Blackwell
American journal of transplantation, 19(10), 2926-2933. Wiley-Blackwell
American Journal of Transplantation, 19, 10, pp. 2926-2933
American Journal of Transplantation
American Journal of Transplantation, 19(10), 2926-2933
American Journal of Transplantation, 19(10), 2926-2933. Wiley-Blackwell Publishing Ltd
American Journal of Transplantation, 19(10), 2926. Blackwell Publishing Asia Pty Ltd
American Journal of Transplantation, 19(10), 2926-2933. Wiley
American Journal of Transplantation, 19, 2926-2933
Whereas regular allocation avoids unacceptable mismatches on the donor organ, allocation to highly sensitized patients within the Eurotransplant Acceptable Mismatch (AM) program is based on the patient's HLA phenotype plus acceptable antigens. These
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19351368da13d7e4600b859d656a764a
https://research.vumc.nl/en/publications/86b120ff-5d3b-4703-beba-4c596a91f3fd
https://research.vumc.nl/en/publications/86b120ff-5d3b-4703-beba-4c596a91f3fd
Publikováno v:
Transplant Immunology, 33(2), 51-57
In 2014, the Eurotransplant Acceptable Mismatch (AM) program celebrated its 25th anniversary. The AM program was initiated to enhance transplantation of highly sensitized patients awaiting a renal transplant within the Eurotransplant region. Unlike t
Publikováno v:
Kidney International, 93(2), 491-500
Highly sensitized renal transplant candidates accumulate on transplant waiting lists since they produce antibodies to many HLA antigens, which in this way become unacceptable. Organ allocation to these patients is usually based on avoiding transplant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2988c34376c1271ee61681f7ba31f08
http://hdl.handle.net/1887/86700
http://hdl.handle.net/1887/86700
Autor:
Henriette Svarre Nielsen, Rudi Steffensen, Geert W. Haasnoot, Ole Bjarne Christiansen, Els Goulmy, Frans H.J. Claas, Marian D. Witvliet
Publikováno v:
Journal of Reproductive Immunology, 87(1-2), 67-73
Nielsen, H S, Witvliet, M D, Steffensen, R, Haasnoot, G W, Goulmy, E, Christiansen, O B & Claas, F 2010, ' The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth ', Journal of Reproductive Immunology, vol. 87, no. 1-2, pp. 67-73 . https://doi.org/10.1016/j.jri.2010.05.006
Nielsen, H S, Witvliet, M D, Steffensen, R, Haasnoot, G W, Goulmy, E, Christiansen, O B & Claas, F 2010, ' The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth ', Journal of Reproductive Immunology, vol. 87, no. 1-2, pp. 67-73 . https://doi.org/10.1016/j.jri.2010.05.006
Anti-paternal HLA-antibodies are considered a harmless phenomenon during most pregnancies, whereas their role in recurrent miscarriage (RM) patients is disputed. In contrast to primary RM, patients with secondary RM have carried a fetus to term pregn
Autor:
Marry de Klerk, Marian D. Witvliet, Willem Weimar, Wilfred M. Van Der Deijl, Bernadette J. J. M. Haase-Kromwijk, Frans H.J. Claas
Publikováno v:
Transplant International. 23:1120-1125
SummaryLiving donor kidney exchange programs offer incompatible donor–recipientpairs the opportunity to be transplanted. To increase the number of thesetransplants, we examined in our actual donor–recipient couples how to reachthe maximum number
Autor:
Arend Mulder, Chantal Eijsink, Marrie J. Kardol, Frans H.J. Claas, Yvonne M. Zoet, Marian D. Witvliet, Ilias I.N. Doxiadis
Publikováno v:
Tissue Antigens. 69:354-357
Sera of highly sensitized patients (HSP) contain complex human leukocyte antigen (HLA) antibodies, minimizing the chance to identify crossmatch-negative donors. Expression of 3-6 HLA class I antigens on lymphocytes hampers identification of acceptabl
Autor:
Willem Weimar, Marian D. Witvliet, Frans H.J. Claas, Marry de Klerk, Bernadette J. J. M. Haase-Kromwijk
Publikováno v:
Transplantation, 82(12), 1616-1620. Lippincott Williams & Wilkins
BACKGROUND Lack of deceased donors for kidney transplant patients in the Netherlands encouraged alternative options to expand the living donor pool for recipients who have a willing donor but cannot donate directly because of a positive crossmatch or
Autor:
Marlies K.A Dankers, Dave L. Roelen, Rene Duquesnoy, Nelleke Korfage, Peter de Lange, Ilias I.N. Doxiadis, Marian D. Witvliet, Frans H.J. Claas, Guido G. Persijn
Publikováno v:
Transplantation. 77:1236-1239
Background. The correlation between antibody production against mismatched donor human leukocyte antigens (HLA) and the number of amino acid sequence mismatches was analyzed in patients who rejected a kidney transplant (n146). Methods. A similar anal
Autor:
Ilias I.N. Doxiadis, Lodewijk A. Sandkuijl, Marlies K.A Dankers, Dave L. Roelen, Nelleke Korfage, Frans H.J. Claas, Marian D. Witvliet, Peter de Lange
Publikováno v:
Human Immunology. 64:600-606
More insight into the differential immunogenicity of human leukocyte antigen (HLA) mismatches will be beneficial for donor selection in clinical transplantation. In this study the immunogenicity of HLA antigens was analyzed by examining the antibody
Autor:
Frans H.J. Claas, Marian D. Witvliet, Marij J. P. Welters, Ad J.J.C. Bogers, Willem Weimar, Lenard M.B. Vaessen, Frans B S Oei, Adri H. Cromme-Dijkhuis
Publikováno v:
Human Immunology, 63, 1019-1025. Elsevier Inc.
Cryopreserved human heart valves are used for valve replacement in patients with congenital or acquired heart disease. Although no blood group or human leukocyte antigens (HLA) matching is performed and no immunosuppression is administered, the clini